Convalescent Plasma Strikes Out As COVID-19 Treatment
Infusing blood plasma from people who have recovered from COVID-19 into sick patients looks good on paper. But studies of the treatment haven't found benefits.
convalescent plasma
Advances In ICU Care Are Saving More Patients Who Have COVID-19
One thing that has improved a lot over the course of the pandemic is treatment of seriously ill COVID-19 patients in intensive care units. Here's one man's success story.
FDA's Hahn Apologizes For Overselling Plasma's Benefits As A COVID-19 Treatment
The Food and Drug Administration's chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.
HHS Chief Alex Azar Defends Authorization Of Plasma To Treat COVID-19
NPR's Ari Shapiro talks with Health and Human Services Secretary Alex Azar about the Food and Drug Administration allowing the use of convalescent plasma to treat COVID-19.
FDA Authorizes Convalescent Plasma As Emergency Treatment For COVID-19
President Trump announced on Sunday that the FDA granted emergency use authorization to treat COVID-19 patients with plasma from people who have recovered from the virus, based on "promising" results.
Trump Wanted FDA To Fast-Track Blood Plasma Therapy. What Is It?
The president criticized the FDA this week for not giving emergency use approval to an experimental treatment for COVID-19. Scientists argue that the therapy still lacks sufficient evidence.